Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model NEW YORK ( TheStreet) -- The ex-dividend date for Becton Dickinson (NYSE: BDX) is tomorrow, September 5, 2012. Owners of shares as of market close today will be eligible for a dividend of 45 cents per share. At a price of $76 as of 10:05 a.m. ET, the dividend yield is 2.4%. The average volume for Becton Dickinson has been one million shares per day over the past 30 days. Becton Dickinson has a market cap of $15.16 billion and is part of the health care sector and health services industry. Shares are up 1.7% year to date as of the close of trading on Friday. Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. The company has a P/E ratio of 13.8, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Becton Dickinson as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, growth in earnings per share, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Becton Dickinson Ratings Report. See our dividend calendar or top-yielding stocks list. FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge! Free download now.